Japan, Sept. 9 -- AXSOME THERAPEUTICS INC has got intellectual property rights for 'ORAL SOLID PHARMACEUTICAL COMPOSITION COMPRISING MELOXICAM AND RIZATRIPTAN.' Other related details are as follows:
Application Number: JP,2024-174072
Category (FI): A61K47/69,A61K9/20,A61P29/00,A61P43/00,121,A61K31/5415,A61K45/00,A61K31/4196,A61K47/02,A61K47/40
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Oct. 3, 2024
Publication Date: Dec. 19, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....